DoseCraft
VapeHeatLab
London Jelly 02012023 L4 Lab Sample
About
London Jelly 02012023 L4 Lab Sample is a hybrid cannabis strain. Lab samples test between 22.4% and 30.3% THC, with caryophyllene (0.99%) as the dominant terpene.
Why does London Jelly 02012023 L4 Lab Sample feel pain-relieving?
London Jelly 02012023 L4 Lab Sample's pain-relieving effects are linked to its dominant caryophyllene (0.99%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by limonene (0.57%), known for mood elevation and stress relief.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 22.4–30.3%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout London Jelly 02012023 L4 Lab Sample
- London Jelly 02012023 L4 Lab Sample is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- London Jelly 02012023 L4 Lab Sample typically tests at 22.4% to 30.3% THC. This is considered a high-potency strain, so start with a low dose if you are new to it.
- The dominant terpenes in London Jelly 02012023 L4 Lab Sample are Caryophyllene, Limonene, Humulene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.